Akros SCHK HK-Global Brain-Computer Interface Index

Q2 2026 earnings release and conference call on August 5, 2026; low impact is estimated as the announcement is a routine scheduling event, scheduled.

Alphabet is scheduled to release its second-quarter 2026 financial results after the market closes on July 22, 2026; analysts forecast focus on Google Cloud and AI growth, with high importance estimated.

Abbott reported Q2 2026 adjusted EPS of $1.31, beating estimates of ~$1.28, and raised its full-year 2026 adjusted EPS guidance to $5.45-$5.60. This guidance raise is estimated to cause a 5-9% price impact expected.

Completed the acquisition of SPR Therapeutics on July 16, 2026, a medical technology company specializing in peripheral nerve stimulation (PNS) therapies for pain management. This acquisition expands Medtronic's pain therapy portfolio.

Johnson & Johnson reported Q2 2026 revenue of $25.3 billion (+6.6% YoY) and adjusted EPS of $2.90, beating analyst estimates. The company raised its full-year 2026 guidance for both sales and earnings.

The ex-dividend date for a quarterly cash dividend of $0.63 per share is July 15, 2026. Routine dividends typically have a price impact of 1-4% scheduled.